Harvard University Now entering the eighth year of Saudi Vision 2030, Saudi Arabia is committed to digital innovation and improvements in high-quality healthcare services. We have achieved great results through improved accessibility. Strategic investments in infrastructure, technology and talent have transformed the way we deliver care to patients while raising local standards of care. Thanks to these efforts, life expectancy in Saudi Arabia has increased significantly, mortality rates have decreased, and overall well-being has improved.

At the heart of these achievements is King Faisal Specialist Hospital and Research Center (KFSH&RC), which has built a reputation for providing specialized medical services and treatments in key areas such as cancer, cardiology, organ transplantation and genetics. As a leader in specialized patient care services, we are leading a brighter and healthier future for Saudi Arabia. Through efforts to pioneer digital health initiatives, comprehensive educational programs, and conducting innovative research, KFSH & RC is reshaping the local medical environment in Saudi Arabia while setting new standards for efficiency and accessibility of medical services.

In an era where technological advancement is prominent, along with Saudi Arabia's digitalization drive, KFSH&RC provides state-of-the-art telemedicine services, virtual treatment, and ANFAL AI that guarantees satisfaction by innovating the medical service outcomes experienced by patients through predictive analysis and customized treatment. By utilizing artificial intelligence-based tools such as the system, we are at the forefront of the digital health integration process among local industry peers.

KFSH&RC's digital health initiative has expanded to address a broader range of health threats through technologies such as whole genome sequencing (WGS) and advanced radiotherapy (ART). He also became a pioneer in the field of organ transplantation by performing the world's first fully robotic liver transplant surgery, and introduced innovative technologies such as the Harmony transcatheter pulmonary valve (TPV) to accelerate recovery and improve the patient experience for patients in Saudi Arabia. These technologies are contributing significantly to improving patient care standards and building a sustainable and resilient healthcare infrastructure by facilitating personalized treatment plans and increasing the accuracy and speed of medical diagnosis, in line with the goals of health sector reform programs.

KFSH&RC continues to push the boundaries of medical research through research achievements such as the discovery of the 'PfAP2-MRP' gene, which is important for malaria treatment, and the identification of a new 'Riyadhensis' bacterial strain, contributing to the development of public health in Saudi Arabia. These findings not only improve diagnostic accuracy but also facilitate early intervention, ensuring timely and effective support for patients, in line with the national goal of reducing the prevalence of chronic diseases.

These comprehensive efforts are also supported by KFSH&RC's robust educational initiatives that nurture the next generation of medical professionals through training programs and international collaborations.

In 2024, it was recognized as the most valuable healthcare brand in Saudi Arabia and the Middle East by 'Brand Finance' for two consecutive years, ranking 9th in Saudi Arabia and 28th in the Middle East. In addition, KFSH&RC is recognized as the only hospital in the world ranked in the top 10 in domestic brand value.

King Faisal Specialist Hospital & Research Centre (KFSH&RC) 소개:

King Faisal Specialty Hospital and Research Center (KFSH&RC) is the best medical institution in the Middle East and aims to be the optimal institution of choice for patients seeking specialized medical services. It boasts a long history in the fields of cancer, cardiovascular disease, organ transplantation, brain science, and genetics.

KFSH&RC was selected as the best academic medical center in the Middle East and Africa by 'Brand Finance' in 2024, ranking alongside the top 20 medical institutions around the world for two consecutive years. In addition, in 2024, Newsweek Magazine selected KFSH&RC as a leading global medical service organization.

On December 21, 2021, as part of 'Saudi Vision 2030', it was reborn as an independent, non-profit, government-owned institution by royal decree, enabling it to carry out a comprehensive reform program to become a global leader in healthcare through excellence and innovation. .

Contact information

If you require more information, please contact us using the contact information below:

Mr. Essam Al-Zahrani, Media Affairs Head, 0555254429

Mr. Abdullah Al-Aown, Media Coordination Officer, 0556294232







Source: globenewswire.com

Report Abuse